Randomized Tandem Study Shows Artificial Intelligence Decreases Adenoma Miss Rate
Douglas K. Rex, MD, MASGE, reviewing Wallace MB, et al. Gastroenterology 2022 Mar 11.
In a randomized tandem study of 230 patients, the adenoma miss rate (AMR) was lower at 15.5% when colonoscopy with artificial intelligence (AI) was performed first versus 32.4% with standard colonoscopy first. Compared with standard colonoscopy, AI-first produced lower AMR for adenomas ≤5 mm (15.9% vs 35.8%) and flat lesions (16.8% vs 45.8%), and it reduced AMR in both the proximal and distal colons. There was no difference in miss rates for lesions ≥10 mm.
Note to readers: At the time we reviewed this paper, its publisher noted that it was not in final form and that subsequent changes might be made.
Wallace MB, Sharma P, Bhandari P, et al. Impact of artificial intelligence on miss rate of colorectal neoplasia. Gastroenterology 2022 Mar 11. (Epub ahead of print) (https://doi.org/10.1053/j.gastro.2022.03.007)